{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:18:03Z","timestamp":1793812683790,"version":"4.6.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["K01 DE030916"],"award-info":[{"award-number":["K01 DE030916"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["R01 DE032216"],"award-info":[{"award-number":["R01 DE032216"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["R21 DE032531"],"award-info":[{"award-number":["R21 DE032531"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006733","name":"Indiana University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006733","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Americas"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.lana.2025.101243","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T07:03:19Z","timestamp":1757919799000},"page":"101243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Two decades of the HPV vaccine: its promise, progress, prospects, projections, and posterity"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3723-9018","authenticated-orcid":false,"given":"Jad","family":"Zeitouni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1390-9753","authenticated-orcid":false,"given":"Nosayaba","family":"Osazuwa-Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2975-2682","authenticated-orcid":false,"given":"Yusuf","family":"Dundar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3835-937X","authenticated-orcid":false,"given":"Gregory","family":"Zimet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Varvares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.lana.2025.101243_bib1","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/AOG.0000000000005056","article-title":"An update on human papillomavirus vaccination in the United States","volume":"141","author":"Boitano","year":"2023","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.lana.2025.101243_bib4","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.oooo.2022.03.016","article-title":"State-of-the-science concepts of HPV-Related oropharyngeal squamous cell carcinoma: a comprehensive review","volume":"134","author":"Louredo","year":"2022","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"6","key":"10.1016\/j.lana.2025.101243_bib5","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.3390\/vaccines11061060","article-title":"Human papillomavirus epidemiology and prevention: is there still a gender gap?","volume":"11","author":"Milano","year":"2023","journal-title":"Vaccines (Basel)"},{"issue":"11","key":"10.1016\/j.lana.2025.101243_bib7","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/OLQ.0000000000000199","article-title":"The estimated impact of human papillomavirus vaccine coverage on the lifetime cervical cancer burden among girls currently aged 12 years and younger in the United States","volume":"41","author":"Chesson","year":"2014","journal-title":"Sex Transm Dis"},{"issue":"30","key":"10.1016\/j.lana.2025.101243_bib8","doi-asserted-by":"crossref","first-page":"466","DOI":"10.15585\/mmwr.mm7430a1","article-title":"Vaccination coverage among adolescents aged 13-17 years - national immunization survey-teen, United States, 2024","volume":"74","author":"Pingali","year":"2025","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.lana.2025.101243_bib9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.2024.22169","article-title":"Cervical cancer mortality among US women younger than 25 years, 1992-2021","volume":"333","author":"Dorali","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.lana.2025.101243_bib10","doi-asserted-by":"crossref","first-page":"96","DOI":"10.15585\/mmwr.mm7406a4","article-title":"Trends in cervical precancers identified through population-based surveillance \u2014 human papillomavirus vaccine impact monitoring project, five sites, United States, 2008\u20132022","volume":"74","author":"Gargano","year":"2025","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"14","key":"10.1016\/j.lana.2025.101243_bib11","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1056\/NEJMoa1917338","article-title":"HPV vaccination and the risk of invasive cervical cancer","volume":"383","author":"Lei","year":"2020","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.lana.2025.101243_bib12","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/jnci\/djad263","article-title":"Invasive cervical cancer incidence following bivalent human papillomavirus vaccination: a population-based observational study of age at immunization, dose, and deprivation","volume":"116","author":"Palmer","year":"2024","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.lana.2025.101243_bib13","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/S2468-2667(18)30183-X","article-title":"The projected timeframe until cervical cancer elimination in Australia: a modelling study","volume":"4","author":"Hall","year":"2019","journal-title":"Lancet Public Health"},{"issue":"10","key":"10.1016\/j.lana.2025.101243_bib14","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2021.2907","article-title":"Projected association of human papillomavirus vaccination with oropharynx cancer incidence in the US, 2020-2045","volume":"7","author":"Zhang","year":"2021","journal-title":"JAMA Oncol"},{"issue":"9","key":"10.1016\/j.lana.2025.101243_bib15","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.31807","article-title":"Human papillomavirus vaccination and human papillomavirus-related cancer rates","volume":"7","author":"Adekanmbi","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.lana.2025.101243_bib16","article-title":"Factors associated with parental human papillomavirus vaccination intentions among adolescents from socioeconomically advantaged versus deprived households: a nationwide, cross-sectional survey","volume":"31","author":"Sonawane","year":"2024","journal-title":"Lancet Reg Health Am"},{"key":"10.1016\/j.lana.2025.101243_bib17","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ypmed.2019.03.037","article-title":"Disparities and reverse disparities in HPV vaccination: a systematic review and meta-analysis","volume":"123","author":"Spencer","year":"2019","journal-title":"Prev Med"},{"issue":"3","key":"10.1016\/j.lana.2025.101243_bib18","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.vaccine.2021.12.003","article-title":"Socioeconomic disadvantage and human papillomavirus (HPV) vaccination uptake","volume":"40","author":"Kurani","year":"2022","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.lana.2025.101243_bib19","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2024.2313249","article-title":"Racial and ethnic disparities in human papillomavirus (HPV) vaccine uptake among United States adults, aged 27-45 years","volume":"20","author":"Rincon","year":"2024","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.lana.2025.101243_bib21","series-title":"How HHS, FDA, and CDC can influence U.S. vaccine policy","author":"Kates","year":"2024"},{"issue":"47","key":"10.1016\/j.lana.2025.101243_bib22","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1016\/j.vaccine.2013.09.031","article-title":"Human papillomavirus (HPV), HPV-associated oropharyngeal cancer, and HPV vaccine in the united States--do we need a broader vaccine policy?","volume":"31","author":"Osazuwa-Peters","year":"2013","journal-title":"Vaccine"},{"issue":"7\u20138","key":"10.1016\/j.lana.2025.101243_bib23","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1080\/21645515.2019.1627817","article-title":"State statutes and regulations related to human papillomavirus vaccination","volume":"15","author":"Hoss","year":"2019","journal-title":"Hum Vaccin Immunother"},{"issue":"11","key":"10.1016\/j.lana.2025.101243_bib24","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1377\/hlthaff.2024.00378","article-title":"School-entry vaccine policies: states' responses to federal recommendations varied from swift to substantially delayed","volume":"43","author":"Larson","year":"2024","journal-title":"Health Aff"},{"issue":"51","key":"10.1016\/j.lana.2025.101243_bib25","doi-asserted-by":"crossref","first-page":"7426","DOI":"10.1016\/j.vaccine.2022.08.019","article-title":"Support for HPV vaccine school-entry requirements in the United States: the role of exemption policies","volume":"40","author":"Calo","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.lana.2025.101243_bib26","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2025.1218","article-title":"How should health care and public health respond to the new US administration?","author":"Woolf","year":"2025","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.lana.2025.101243_bib27","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2022-060410","article-title":"Trends in reasons for human papillomavirus vaccine hesitancy: 2010-2020","volume":"151","author":"Adjei Boakye","year":"2023","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.lana.2025.101243_bib28","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1177\/003335490812300617","article-title":"Childhood vaccine and school entry laws: the case of HPV vaccine","volume":"123","author":"Stewart","year":"2008","journal-title":"Public Health Rep"},{"issue":"4","key":"10.1016\/j.lana.2025.101243_bib30","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3390\/vaccines12040401","article-title":"Perceptions of a state-level HPV vaccine mandate and exemption option in rural Virginia: a qualitative study","volume":"12","author":"Brooks","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.lana.2025.101243_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhealeco.2021.102480","article-title":"How important is the structure of school vaccine requirement opt-out provisions? Evidence from Washington, DC's HPV vaccine requirement","volume":"78","author":"Churchill","year":"2021","journal-title":"J Health Econ"},{"issue":"8","key":"10.1016\/j.lana.2025.101243_bib32","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.3390\/vaccines11081359","article-title":"Attitudes towards HPV vaccination policy strategies to improve adolescent vaccination coverage among pediatric providers in New York state","volume":"11","author":"Shaw","year":"2023","journal-title":"Vaccines (Basel)"},{"issue":"11","key":"10.1016\/j.lana.2025.101243_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0000782","article-title":"Human papillomavirus vaccine initiation and up-to-date vaccine coverage for adolescents after the implementation of school-entry policy in Puerto Rico","volume":"2","author":"Col\u00f3n-L\u00f3pez","year":"2022","journal-title":"PLOS Glob Public Health"},{"issue":"5","key":"10.1016\/j.lana.2025.101243_bib34","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1177\/1049732321991507","article-title":"The intersection of problems, policy, and politics: the adoption of an HPV vaccine school-entry requirement in Puerto Rico","volume":"31","author":"V\u00e1zquez-Otero","year":"2021","journal-title":"Qual Health Res"},{"issue":"11","key":"10.1016\/j.lana.2025.101243_bib35","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1080\/21645515.2021.1955609","article-title":"Implementation of the human papillomavirus school-entry requirement in Puerto Rico: barriers and facilitators using the consolidated framework for implementation research","volume":"17","author":"Col\u00f3n-L\u00f3pez","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.lana.2025.101243_bib37","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jpeds.2021.01.026","article-title":"Adolescent consent for human papillomavirus vaccine: ethical, legal, and practical considerations","volume":"231","author":"Zimet","year":"2021","journal-title":"J Pediatr"},{"issue":"10","key":"10.1016\/j.lana.2025.101243_bib39","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.2105\/AJPH.2018.304552","article-title":"Human papillomavirus vaccine initiation for adolescents following Rhode Island's school-entry requirement, 2010-2016","volume":"108","author":"Thompson","year":"2018","journal-title":"Am J Public Health"},{"issue":"5","key":"10.1016\/j.lana.2025.101243_bib40","first-page":"64","article-title":"Cervical precancer among Rhode Island women, 2018-2019: a quick report after the Rhode Island cancer surveillance regulation change","volume":"105","author":"Oh","year":"2022","journal-title":"R I Med J (2013)"},{"issue":"29","key":"10.1016\/j.lana.2025.101243_bib41","doi-asserted-by":"crossref","first-page":"784","DOI":"10.15585\/mmwr.mm6429a3","article-title":"National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 Years--United states, 2014","volume":"64","author":"Reagan-Steiner","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"10.1016\/j.lana.2025.101243_bib42","doi-asserted-by":"crossref","first-page":"752.e1","DOI":"10.1016\/j.ajog.2016.03.022","article-title":"Rates of human papillomavirus vaccine uptake amongst girls five years after introduction of statewide mandate in Virginia","volume":"214","author":"Cuff","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.lana.2025.101243_bib43","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/s12889-021-10328-4","article-title":"Associations between insurance-related affordable care act policy changes with HPV vaccine completion","volume":"21","author":"Hawkins","year":"2021","journal-title":"BMC Public Health"},{"issue":"6","key":"10.1016\/j.lana.2025.101243_bib44","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2122494","article-title":"Overcoming barriers to HPV vaccination in rural Vermont through a multicomponent peer-based approach","volume":"18","author":"Pilcher","year":"2022","journal-title":"Hum Vaccin Immunother"},{"issue":"1\u20132","key":"10.1016\/j.lana.2025.101243_bib45","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s10865-022-00316-3","article-title":"HPV and COVID-19 vaccines: social media use, confidence, and intentions among parents living in different community types in the United States","volume":"46","author":"Manganello","year":"2023","journal-title":"J Behav Med"},{"issue":"11","key":"10.1016\/j.lana.2025.101243_bib46","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1080\/21645515.2020.1780846","article-title":"Social media and vaccine hesitancy: new updates for the era of COVID-19 and globalized infectious diseases","volume":"16","author":"Puri","year":"2020","journal-title":"Hum Vaccin Immunother"},{"issue":"7","key":"10.1016\/j.lana.2025.101243_bib47","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3390\/vaccines9070687","article-title":"A systematic review of interventions to improve HPV vaccination coverage","volume":"9","author":"Mavundza","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.lana.2025.101243_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2021.106554","article-title":"Provider communication and HPV vaccine uptake: a meta-analysis and systematic review","volume":"148","author":"Oh","year":"2021","journal-title":"Prev Med"},{"issue":"20","key":"10.1016\/j.lana.2025.101243_bib49","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1016\/j.vaccine.2022.03.028","article-title":"Disparities in human papillomavirus vaccination coverage in the United States, national health and nutrition examination survey, January 2017-March 2020","volume":"40","author":"Lewis","year":"2022","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.lana.2025.101243_bib50","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.amepre.2017.08.024","article-title":"Health insurance status and clinical cancer screenings among U.S. adults","volume":"54","author":"Zhao","year":"2018","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.lana.2025.101243_bib51","first-page":"50","article-title":"The affordable care act and change in human papillomavirus (HPV) vaccine uptake in the United States","author":"Gao","year":"2025","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.lana.2025.101243_bib52","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1001\/jamapediatrics.2020.1852","article-title":"Association between human papillomavirus vaccination school-entry requirements and vaccination initiation","volume":"174","author":"Ko","year":"2020","journal-title":"JAMA Pediatr"},{"issue":"6","key":"10.1016\/j.lana.2025.101243_bib53","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1080\/21645515.2015.1122145","article-title":"Increasing HPV vaccination through policy for public health benefit","volume":"12","author":"Brandt","year":"2016","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"10.1016\/j.lana.2025.101243_bib54","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1001\/jamapediatrics.2018.3327","article-title":"Human papillomavirus vaccination and school entry requirements: politically challenging, but not impossible","volume":"173","author":"Daley","year":"2019","journal-title":"JAMA Pediatr"},{"issue":"35","key":"10.1016\/j.lana.2025.101243_bib55","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.1016\/j.vaccine.2019.05.062","article-title":"Perceptions of politicization and HPV vaccine policy support","volume":"37","author":"Saulsberry","year":"2019","journal-title":"Vaccine"},{"issue":"7\u20138","key":"10.1016\/j.lana.2025.101243_bib56","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1080\/21645515.2018.1553475","article-title":"Policy opportunities to increase HPV vaccination in rural communities","volume":"15","author":"Vanderpool","year":"2019","journal-title":"Hum Vaccin Immunother"}],"container-title":["The Lancet Regional Health - Americas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667193X25002534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667193X25002534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T21:55:28Z","timestamp":1772920528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667193X25002534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":49,"alternative-id":["S2667193X25002534"],"URL":"https:\/\/doi.org\/10.1016\/j.lana.2025.101243","relation":{},"ISSN":["2667-193X"],"issn-type":[{"value":"2667-193X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Two decades of the HPV vaccine: its promise, progress, prospects, projections, and posterity","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Americas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lana.2025.101243","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101243"}}